IN DEPTH

Going beyond the mirage of complete skin clearance in psoriasis

As Russia’s clinical trials sector falls, Ukraine rebuilds

CMO Moves: Regulatory catalysts for drug manufacturing- September

R&D

Exploring the promise of billion-dollar KRAS drugs

KRAS mutations are one of the most prevalent drivers of cancer, yet they were long considered ‘undruggable’. A new wave of drugs is changing that.

R&D

Nanorobots: small solutions to big delivery problems

FDI

Foreign investments amplify the nucleic acid therapeutics field 

Going beyond the mirage of complete skin clearance in psoriasis 

As Russia’s clinical trials sector falls, Ukraine rebuilds

CMO Moves: Regulatory catalysts for drug manufacturing- September